NCT00138749已完成2 期
An 8-Week, Multi-Centre,Randomised Double-Blind, Placebo Controlled, Parallel Group Study To Evaluate The Efficacy,Toleration And Safety Of (+)- [S,S]- Reboxetine In The Treatment Of Stress Urinary Incontinence (SUI) In Women.
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 402
- 试验地点
- 96
- 主要终点
- Proof of concept study to assess the efficacy, tolerability and safety of SS-RBX vs. placebo in the treatment of SUI.
研究概览
简要总结
A study designed to assess the efficacy, toleration and safety of SS-RBX for the treatment of stress urinary incontinence.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Clinically significant stress urinary incontinence
排除标准
- •History or evidence of any relevant confounding urological or neurological disease
结局指标
主要结局
Proof of concept study to assess the efficacy, tolerability and safety of SS-RBX vs. placebo in the treatment of SUI.
次要结局
- To evaluate whether an upward dose adjustment affects the tolerability of SS-RBX.
研究者
研究点 (96)
Loading locations...
相似试验
已完成
不适用
The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell TransplantationBone Marrow NeoplasmsQuality of LifeAdherence, MedicationCoping SkillsAdolescent BehaviorCancerDepressionAnxietyNCT03640325Seattle Children's Hospital143
Enrolling By Invitation
不适用
A RCT of Psychosocial Interventions Facilitating Positive Psychological Adaptation in Breast CancerBreast Cancer FemaleNCT06531135Koo Foundation Sun Yat-Sen Cancer Center200
已完成
3 期
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive DisorderTreatment Resistant Major Depressive DisorderNCT02741791Axsome Therapeutics, Inc.312
已完成
不适用
Training Parents of Children With ADHD by Mindfulness-based Stress Reduction for Reducing StressStress, PsychologicalNCT06210113The Hong Kong Polytechnic University36
已完成
不适用
The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced CancerCancerQuality of LifeHopeCoping SkillsCommunicationAnxietyDepressionNCT03668223Dana-Farber Cancer Institute195